MAC-话题@MedSci

#MAC#

655篇内容 | 2709人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1996281, encodeId=5c9e199628142, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int Immunopharmacol：没食子酸能减轻过敏性鼻炎模型中的鼻腔炎症, objectType=article, longId=163702, objectId=69dd163e02ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69dd163e02ec, replyNumber=0, likeNumber=68, createdTime=2019-08-29, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69dd163e02ec, moduleTitle=Int Immunopharmacol：没食子酸能减轻过敏性鼻炎模型中的鼻腔炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69dd163e02ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996308, encodeId=d753199630846, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡, objectType=article, longId=177301, objectId=41851e73015c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41851e73015c, replyNumber=0, likeNumber=54, createdTime=2019-08-30, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41851e73015c, moduleTitle=Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41851e73015c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996303, encodeId=7817199630376, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展, objectType=article, longId=175404, objectId=17361e54044b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17361e54044b, replyNumber=0, likeNumber=0, createdTime=2020-04-25, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17361e54044b, moduleTitle=Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17361e54044b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996268, encodeId=d7f519962689e, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci：MicroRNA-9-5p通过靶向Wnt3a抑制骨生成和促进脂肪生成，促进骨质疏松症的发展, objectType=article, longId=159563, objectId=7dc9159563bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dc9159563bd, replyNumber=0, likeNumber=62, createdTime=2019-07-04, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dc9159563bd, moduleTitle=Eur Rev Med Pharmacol Sci：MicroRNA-9-5p通过靶向Wnt3a抑制骨生成和促进脂肪生成，促进骨质疏松症的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dc9159563bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996323, encodeId=3a761996323e3, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=MacroGenics宣布HER2单抗Margetuximab在转移性乳腺癌患者中的III期临床SOPHIA的第二次总体中期生存数据, objectType=article, longId=181811, objectId=3a1a18181105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a1a18181105, replyNumber=0, likeNumber=51, createdTime=2020-09-18, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a1a18181105, moduleTitle=MacroGenics宣布HER2单抗Margetuximab在转移性乳腺癌患者中的III期临床SOPHIA的第二次总体中期生存数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a1a18181105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996266, encodeId=7aa0199626664, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biomed Pharmacother：地塞米松通过ROS-PI3K/AKT/GSK3β信号通路诱导成骨细胞凋亡, objectType=article, longId=159495, objectId=60281594950a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60281594950a, replyNumber=0, likeNumber=63, createdTime=2019-04-02, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60281594950a, moduleTitle=Biomed Pharmacother：地塞米松通过ROS-PI3K/AKT/GSK3β信号通路诱导成骨细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60281594950a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996257, encodeId=bb2e199625e7d, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci：在前列腺癌细胞中，miR-195对MAP2K1的靶向调控能够抑制ADM药物抗性, objectType=article, longId=157435, objectId=d46015e435bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d46015e435bf, replyNumber=0, likeNumber=70, createdTime=2019-02-02, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d46015e435bf, moduleTitle=Eur Rev Med Pharmacol Sci：在前列腺癌细胞中，miR-195对MAP2K1的靶向调控能够抑制ADM药物抗性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d46015e435bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996272, encodeId=a19819962e213, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Neuropsychopharmacology：女性荷尔蒙在成瘾中的作用：复发率更高, objectType=article, longId=159793, objectId=e610159e932e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e610159e932e, replyNumber=0, likeNumber=57, createdTime=2019-03-10, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e610159e932e, moduleTitle=Neuropsychopharmacology：女性荷尔蒙在成瘾中的作用：复发率更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e610159e932e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996270, encodeId=d92d19962e08f, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：富含类黄酮的佛手柑汁提取物改善脂多糖诱导的牙周炎, objectType=article, longId=159590, objectId=c3a1159590ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3a1159590ca, replyNumber=0, likeNumber=64, createdTime=2019-11-01, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3a1159590ca, moduleTitle=Front Pharmacol：富含类黄酮的佛手柑汁提取物改善脂多糖诱导的牙周炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3a1159590ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996290, encodeId=cbc41996290f0, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biomed Pharmacother：宝霍赛德I抗骨质疏松活性的初步研究, objectType=article, longId=165386, objectId=e65f1653861d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e65f1653861d, replyNumber=0, likeNumber=68, createdTime=2019-09-17, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e65f1653861d, moduleTitle=Biomed Pharmacother：宝霍赛德I抗骨质疏松活性的初步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e65f1653861d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996288, encodeId=299e199628858, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int J Biol Macromol：TGF-β1通过下调成骨细胞中miR-203a-5p刺激基质金属蛋白酶-13的表达, objectType=article, longId=165174, objectId=97221651e4c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97221651e4c6, replyNumber=0, likeNumber=57, createdTime=2019-07-16, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97221651e4c6, moduleTitle=Int J Biol Macromol：TGF-β1通过下调成骨细胞中miR-203a-5p刺激基质金属蛋白酶-13的表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97221651e4c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996247, encodeId=59e4199624e5d, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Clin Pharmacol Ther：伏立康唑治疗成人侵袭性真菌感染更佳剂量如何确定？, objectType=article, longId=156116, objectId=46171561169a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46171561169a, replyNumber=0, likeNumber=79, createdTime=2019-07-24, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46171561169a, moduleTitle=Clin Pharmacol Ther：伏立康唑治疗成人侵袭性真菌感染更佳剂量如何确定？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46171561169a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996321, encodeId=3cc019963219b, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险, objectType=article, longId=181662, objectId=2258181662f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2258181662f7, replyNumber=0, likeNumber=53, createdTime=2020-02-25, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2258181662f7, moduleTitle=Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2258181662f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996254, encodeId=c697199625418, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci：MiR-488通过靶向DKK1促进骨折愈合, objectType=article, longId=157011, objectId=bb9115e01139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb9115e01139, replyNumber=0, likeNumber=48, createdTime=2019-06-24, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb9115e01139, moduleTitle=Eur Rev Med Pharmacol Sci：MiR-488通过靶向DKK1促进骨折愈合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb9115e01139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996282, encodeId=41841996282ec, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：基于洛匹那韦/利托那韦的**和替代二线方案在HIV感染患者中的疗效, objectType=article, longId=164255, objectId=4e0616425517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e0616425517, replyNumber=0, likeNumber=55, createdTime=2019-04-26, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e0616425517, moduleTitle=Front Pharmacol：基于洛匹那韦/利托那韦的**和替代二线方案在HIV感染患者中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e0616425517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996258, encodeId=980619962587b, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Ann Pharmacother：心脏手术患者围手术期镇静：基于右美托咪定vs基于丙泊酚方案, objectType=article, longId=157467, objectId=12e215e467ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12e215e467ff, replyNumber=0, likeNumber=58, createdTime=2019-07-19, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12e215e467ff, moduleTitle=Ann Pharmacother：心脏手术患者围手术期镇静：基于右美托咪定vs基于丙泊酚方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12e215e467ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996251, encodeId=ff5c199625104, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biomed Pharmacother：FGF-21对肝细胞生长因子（HGF）介导的PI3K/AKT信号通路对种植体骨缺损的影响, objectType=article, longId=156812, objectId=dc5b15681213, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc5b15681213, replyNumber=0, likeNumber=71, createdTime=2019-01-16, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc5b15681213, moduleTitle=Biomed Pharmacother：FGF-21对肝细胞生长因子（HGF）介导的PI3K/AKT信号通路对种植体骨缺损的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc5b15681213)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996245, encodeId=4da61996245ef, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Clin Pharmacol Ther：他汀一级预防再获力证不同冠心病风险人群均有获益, objectType=article, longId=156112, objectId=761f15611247, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=761f15611247, replyNumber=0, likeNumber=52, createdTime=2019-01-31, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=761f15611247, moduleTitle=Clin Pharmacol Ther：他汀一级预防再获力证不同冠心病风险人群均有获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=761f15611247)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996301, encodeId=76f8199630155, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biomed Pharmacother：长非编码RNA SNHG16对miR-140-5p具有海绵促进人视网膜母细胞瘤发生发展, objectType=article, longId=174474, objectId=94081e4474dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94081e4474dd, replyNumber=0, likeNumber=54, createdTime=2019-07-13, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94081e4474dd, moduleTitle=Biomed Pharmacother：长非编码RNA SNHG16对miR-140-5p具有海绵促进人视网膜母细胞瘤发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94081e4474dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996274, encodeId=7f6619962e459, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Bexion Pharmaceuticals宣布开展I期试验的第3部分以评价BXQ-350治疗癌症的可行性, objectType=article, longId=161122, objectId=d5d316112204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5d316112204, replyNumber=0, likeNumber=79, createdTime=2020-02-03, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5d316112204, moduleTitle=Bexion Pharmaceuticals宣布开展I期试验的第3部分以评价BXQ-350治疗癌症的可行性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5d316112204)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MAC

2020-05-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int Immunopharmacol：没食子酸能减轻过敏性鼻炎模型中的鼻腔炎症

2019-08-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡

2019-08-30

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展

2020-04-25

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci：MicroRNA-9-5p通过靶向Wnt3a抑制骨生成和促进脂肪生成，促进骨质疏松症的发展

2019-07-04

yb6560 (审核中...)

前往app查看评论内容

#MAC#

MacroGenics宣布HER2单抗Margetuximab在转移性乳腺癌患者中的III期临床SOPHIA的第二次总体中期生存数据

2020-09-18

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biomed Pharmacother：地塞米松通过ROS-PI3K/AKT/GSK3β信号通路诱导成骨细胞凋亡

2019-04-02

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci：在前列腺癌细胞中，miR-195对MAP2K1的靶向调控能够抑制ADM药物抗性

2019-02-02

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Neuropsychopharmacology：女性荷尔蒙在成瘾中的作用：复发率更高

2019-03-10

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：富含类黄酮的佛手柑汁提取物改善脂多糖诱导的牙周炎

2019-11-01

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biomed Pharmacother：宝霍赛德I抗骨质疏松活性的初步研究

2019-09-17

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int J Biol Macromol：TGF-β1通过下调成骨细胞中miR-203a-5p刺激基质金属蛋白酶-13的表达

2019-07-16

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Clin Pharmacol Ther：伏立康唑治疗成人侵袭性真菌感染更佳剂量如何确定？

2019-07-24

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险

2020-02-25

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci：MiR-488通过靶向DKK1促进骨折愈合

2019-06-24

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：基于洛匹那韦/利托那韦的**和替代二线方案在HIV感染患者中的疗效

2019-04-26

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Ann Pharmacother：心脏手术患者围手术期镇静：基于右美托咪定vs基于丙泊酚方案

2019-07-19

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biomed Pharmacother：FGF-21对肝细胞生长因子（HGF）介导的PI3K/AKT信号通路对种植体骨缺损的影响

2019-01-16

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Clin Pharmacol Ther：他汀一级预防再获力证不同冠心病风险人群均有获益

2019-01-31

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biomed Pharmacother：长非编码RNA SNHG16对miR-140-5p具有海绵促进人视网膜母细胞瘤发生发展

2019-07-13

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Bexion Pharmaceuticals宣布开展I期试验的第3部分以评价BXQ-350治疗癌症的可行性

2020-02-03

科室
- - 订阅+
  - 更多科室
工具
服务